↓ Skip to main content

Dove Medical Press

Anxiety and depression in patients with advanced macular degeneration: current perspectives

Overview of attention for article published in Clinical Ophthalmology, December 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#19 of 3,712)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
16 news outlets
twitter
14 X users
facebook
1 Facebook page

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
130 Mendeley
Title
Anxiety and depression in patients with advanced macular degeneration: current perspectives
Published in
Clinical Ophthalmology, December 2015
DOI 10.2147/opth.s80489
Pubmed ID
Authors

Verena R Cimarolli, Robin J Casten, Barry W Rovner, Vera Heyl, Silvia Sörensen, Amy Horowitz

Abstract

Age-related macular degeneration (AMD) - despite advances in prevention and medical treatment options - remains prevalent among older adults, often resulting in functional losses that negatively affect the mental health of older adults. In particular, the prevalence of both anxiety and depression in patients with AMD is high. Along with medical treatment options, low vision rehabilitation and AMD-specific behavioral and self-management programs have been developed and have demonstrated effectiveness in improving the mental health of AMD patients. This article reviews the prevalence of anxiety and depression in patients with advanced AMD, discusses potential mechanisms accounting for the development of depression and anxiety in AMD patients, presents the state-of the-art of available interventions for addressing anxiety and depression in AMD patients, and delineates recommendations for eye care professionals regarding how to screen for these two prevalent mental health problems and how to facilitate appropriate treatment for patients with AMD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 130 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 24 18%
Student > Master 14 11%
Student > Ph. D. Student 11 8%
Researcher 10 8%
Student > Doctoral Student 8 6%
Other 22 17%
Unknown 41 32%
Readers by discipline Count As %
Medicine and Dentistry 31 24%
Nursing and Health Professions 11 8%
Psychology 9 7%
Biochemistry, Genetics and Molecular Biology 6 5%
Neuroscience 5 4%
Other 26 20%
Unknown 42 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 125. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2022.
All research outputs
#333,391
of 25,374,647 outputs
Outputs from Clinical Ophthalmology
#19
of 3,712 outputs
Outputs of similar age
#5,324
of 395,421 outputs
Outputs of similar age from Clinical Ophthalmology
#1
of 70 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,712 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,421 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.